Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise {Roots Analysis}

The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process. Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers.

To order this 320+ page report, which features 45+ figures and 100+ tables, please visit this – https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

The USD 6+ billion (by 2030) financial opportunity associated with nuclear medicine and radiopharmaceuticals manufacturing, has been analyzed across the following segments:

• Target Disease Indication 

• Breast Cancer
• Chronic Lymphocytic Leukemia
• Colorectal Cancer
• Head and Neck Cancer
• Lung Cancer
• Lupus Nephritis
• Melanoma
• Multiple Myeloma
• Primary Sjögren’s Syndrome
• Others 

• Target Immune Checkpoint

• B7-H3
• CD38
• CD40
• CD47
• Others

• Mechanism of Action

• Inhibitory
• Stimulatory

• Therapeutic Modality

• Monoclonal Antibody
• Small Molecule

• Type of Therapy 

• Monotherapy 
• Combination Therapy

• Route of Administration

• Intravenous
• Subcutaneous
• Others

• Key Geographical Regions 

• North America
• Europe
• Asia-Pacific and the Rest of the World 

The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” report features the following companies, which we identified to be key players in this domain:

• Advanced Accelerator Applications
• Belgian Nuclear Research Center (SCK•CEN)
• Cardinal Health
• China Isotope & Radiation Corporation
• Curium Pharma
• DuChemBio
• Eckert & Ziegler
• Eczacibasi-Monrol
• GE Healthcare
• Jubilant DraxImage
• Lantheus Medical Imaging
• Nihon Medi-Physics
• Nordion
• PETNET Solutions
• SinoTau Pharmaceuticals
• SOFIE

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape

5. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Non-Industry Players): Current Market Landscape

6. Nuclear Medicine and Radiopharmaceuticals Manufacturers in North America

7. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Europe

8. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World

9. Nuclear Medicine and Radiopharmaceuticals Manufacturers: Company Competitiveness Analysis

10. Partnerships and Collaborations

11. Production and Supply Chain of Medical Isotope Molybdenum-99 (Technetium-99m)

12. Market Forecast and Opportunity Analysis

13. Concluding Remarks

14. Executive Insights

15. Appendix 1: Tabulated Data

16. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com